Jung SH - Search Results

1

Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma.

Lee H, Kim KR, Noh SJ, Park HS, Kwon KS, Park BH, Jung SH, Youn HJ, Lee BK, Chung MJ, Koh DH, Moon WS, Jang KY. Lee H, et al. Among authors: jung sh. Hum Pathol. 2011 Feb;42(2):204-13. doi: 10.1016/j.humpath.2010.05.023. Epub 2010 Nov 5. Hum Pathol. 2011. PMID: 21056897

2

Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis, but not angiogenesis, of breast cancer.

Chung MJ, Jung SH, Lee BJ, Kang MJ, Lee DG. Chung MJ, et al. Among authors: jung sh. Pathol Int. 2004 Jan;54(1):10-5. doi: 10.1111/j.1440-1827.2004.01576.x. Pathol Int. 2004. PMID: 14674989

3

Glycogen-rich clear cell mammary malignant myoepithelioma.

Son HJ, Jung SH, Lee SY, Moon WS. Son HJ, et al. Among authors: jung sh. Breast. 2004 Dec;13(6):506-9. doi: 10.1016/j.breast.2004.07.003. Breast. 2004. PMID: 15563859 Review.

4

Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.

Lee YR, Park J, Yu HN, Kim JS, Youn HJ, Jung SH. Lee YR, et al. Among authors: jung sh. Biochem Biophys Res Commun. 2005 Nov 4;336(4):1221-6. doi: 10.1016/j.bbrc.2005.08.256. Biochem Biophys Res Commun. 2005. PMID: 16169518

5

Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.

Yu HN, Lee YR, Noh EM, Lee KS, Kim JS, Song EK, Han MK, Lee YC, Kwon KB, Lee SJ, Youn HJ, Jung SH. Yu HN, et al. Among authors: jung sh. Cell Biol Int. 2008 Aug;32(8):906-12. doi: 10.1016/j.cellbi.2008.04.011. Epub 2008 Apr 10. Cell Biol Int. 2008. PMID: 18474441

6

Effect of xanthohumol on melanogenesis in B16 melanoma cells.

Koo JH, Kim HT, Yoon HY, Kwon KB, Choi IW, Jung SH, Kim HU, Park BH, Park JW. Koo JH, et al. Among authors: jung sh. Exp Mol Med. 2008 Jun 30;40(3):313-9. doi: 10.3858/emm.2008.40.3.313. Exp Mol Med. 2008. PMID: 18587269 Free PMC article.

7

Troglitazone enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells.

Yu HN, Noh EM, Lee YR, Roh SG, Song EK, Han MK, Lee YC, Shim IK, Lee SJ, Jung SH, Kim JS, Youn HJ. Yu HN, et al. Among authors: jung sh. Biochem Biophys Res Commun. 2008 Dec 5;377(1):242-7. doi: 10.1016/j.bbrc.2008.09.111. Epub 2008 Oct 7. Biochem Biophys Res Commun. 2008. PMID: 18835379

8

Cordycepin inhibits TPA-induced matrix metalloproteinase-9 expression by suppressing the MAPK/AP-1 pathway in MCF-7 human breast cancer cells.

Noh EM, Youn HJ, Jung SH, Han JH, Jeong YJ, Chung EY, Jung JY, Kim BS, Lee SH, Lee YR, Kim JS. Noh EM, et al. Among authors: jung jy, jung sh. Int J Mol Med. 2010 Feb;25(2):255-60. Int J Mol Med. 2010. PMID: 20043135

9

Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis.

Lee EH, Park SK, Park B, Kim SW, Lee MH, Ahn SH, Son BH, Yoo KY, Kang D; KOHBRA Research Group; Korean Breast Cancer Society. Lee EH, et al. Breast Cancer Res Treat. 2010 Jul;122(1):11-25. doi: 10.1007/s10549-010-0859-2. Epub 2010 Apr 8. Breast Cancer Res Treat. 2010. PMID: 20376556 Review.

10

Accessory Breast Carcinoma.

Youn HJ, Jung SH. Youn HJ, et al. Among authors: jung sh. Breast Care (Basel). 2009;4(2):104-106. doi: 10.1159/000210638. Epub 2009 Apr 24. Breast Care (Basel). 2009. PMID: 20847887 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,224 results

Search Page